WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 2 fonti

NHS must pay ‘fair share’, says US drug giant amid Trump pressure

Drugmaker echoes president’s insistence that overseas health services fund new treatments

Raccontata dafortune.comtelegraph.co.uk

Confronto fonti

2 prospettive sulla stessa storia
AI · summaries
telegraph.co.ukStai leggendo9 mesi fa

NHS must pay ‘fair share’, says US drug giant amid Trump pressure

Drugmaker echoes president’s insistence that overseas health services fund new treatments

originale
fortune.com9 mesi fa

Swiss drug giant looks for ways to lower U.S. prices amid tariff threat and admits Americans 'pay for a large…

"We are working with the government and trying to find constructive solutions so that Americans pay less for their medicines."

Leggi questa versione → originale

Timeline cronologica

  1. sabato 20 settembre 2025·fortune.com

    Swiss drug giant looks for ways to lower U.S. prices amid tariff threat and admits Americans 'pay for a large part of the innovations' |…

    "We are working with the government and trying to find constructive solutions so that Americans pay less for their medicines."

  2. lunedì 22 settembre 2025·telegraph.co.uk

    NHS must pay ‘fair share’, says US drug giant amid Trump pressure

    Drugmaker echoes president’s insistence that overseas health services fund new treatments

  • mercoledì 24 settembre 2025·telegraph.co.uk

    NHS risks missing out on new drugs, warns Mounjaro maker

    Eli Lilly calls on Britain’s health service to pay higher prices for medicines